Insights On Trial Design

  1. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

    Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

  2. Why Site Engagement Belongs At Investigators' Meetings 8/4/2026

    Investigators’ meetings are a great opportunity to give sites direct access to the teams supporting patient travel and reimbursement, clarify available services early, and surface practical needs before they become study barriers.

  3. How Community Engagement Drives Better Study Outcomes 4/22/2026

    Examples of how embedded community sites and local events show how authentic on‑the‑ground involvement translates into deeper patient relationships and measurable study outcomes.

  4. Korio RTSM Platform: Dosing Configuration Demo 3/16/2026

    Protocols evolve — and Korio is built to evolve with them. In this demo, see how users can easily add new doses, configure dose use rules, and define logic for dose adjustments based on visit history or other criteria.

  5. Pharmacy Considerations For Early Phase Trials 5/8/2026

    This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.

  6. Improving The Patient Experience In Clinical Research 2/6/2025

    To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

  7. Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views 9/23/2025

    Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.

  8. Think U.S.A.: The Operations Behind Your Clinical Trials 1/22/2025

    Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.

  9. How Adaptive Design Accelerates Early‑Phase NSCLC Development 5/22/2026

    Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.

  10. Why Life Science Organizations Need A Chief Patient Officer Function 4/27/2026

    Bridging the gap between innovation and impact, this exploration of the Chief Patient Officer role offers a strategic framework to integrate patient insights and de-risk the product lifecycle.